Higher Prevalence of Secretory CSE1L/CAS in Sera of Patients with Metastatic Cancer
Open Access
- 1 May 2009
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 18 (5) , 1570-1577
Abstract
Metastatic markers are highly useful diagnostic and prognostic indicators of cancer metastasis. Herein, we report that secretory CSE1L/CAS, a cellular apoptosis susceptibility protein, is a new marker for metastatic cancer. CAS was colocalized with matrix metalloproteinase-2 in vesicles surrounding the outside of MCF-7 cell membranes, and the COOH-terminal domain of CAS was associated with matrix metalloproteinase-2-containing vesicles. Immunohistochemical staining for CAS was positive in the stroma and gland lumens of human metastatic cancer tissues. CAS was also detected in conditioned medium from B16-F10 melanoma cells and more frequently in the sera of patients with metastatic cancer than in sera from patients with primary cancer. Specifically, the prevalence of serum CAS in serum samples from 146 patients was 58.2% (32 of 55), 32.0% (8 of 25), and 12.1% (8 of 66) for patients with metastatic, invasive, and primary cancers, respectively. Our results suggest that CAS is a secretory protein associated with cancer metastasis, which may have clinical utility in metastatic cancer screening and diagnosis. (Cancer Epidemiol Biomarkers Prev 2009;18(5):1570–7)Keywords
This publication has 23 references indexed in Scilit:
- CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cellsJournal of Experimental & Clinical Cancer Research, 2008
- CAS Enhances Chemotherapeutic Drug-Induced p53 Accumulation and Apoptosis: Use of CAS for High-Sensitivity Anticancer Drug ScreeningToxicology Mechanisms and Methods, 2008
- Biomarkers for Cancer Risk, Early Detection, and Prognosis: The Validation ConundrumCancer Epidemiology, Biomarkers & Prevention, 2007
- Control of matrix metalloproteinase catalytic activityMatrix Biology, 2007
- The Role of Osteopontin in Tumor Progression and Metastasis in Breast CancerCancer Epidemiology, Biomarkers & Prevention, 2007
- Extracellular Activity of Cyclic AMP–Dependent Protein Kinase as a Biomarker for Human Cancer Detection: Distribution Characteristics in a Normal Population and Cancer PatientsCancer Epidemiology, Biomarkers & Prevention, 2007
- Pooling of Case Specimens to Create Standard Serum Sets for Screening Cancer BiomarkersCancer Epidemiology, Biomarkers & Prevention, 2007
- Tumor–stroma interactions: their role in the control of tumor cell invasionBiochimie, 2005
- Matrix metalloproteinase‐2 (MMP‐2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP‐ribose) polymerase (PARP) in vitroThe FASEB Journal, 2004
- Tumor Cell Interactions with the Extracellular Matrix During Invasion and MetastasisAnnual Review of Cell Biology, 1993